 WATERTOWN, Mass., Nov. 11, 2020 GLOBE NEWSWIRE -- Kymera Therapeutics, Inc. NASDAQ: KYMR, a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the bodys own natural protein degradation system, today announced Nello Mainolfi, Co-Founder, President and CEO of Kymera Therapeutics, will present at the Stifel 2020 Virtual Healthcare Conference at 8:00 a.m. ET on Tuesday, November 17, 2020. 